{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-22-000951","form_type":"8-K","ticker":"INNV","cik":"0001834376","company_name":"InnovAge Holding Corp.","filed_at":"2022-02-09T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.689176+00:00","generated_at":"2026-06-27T09:41:21.723152+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"InnovAge Q2 EPS $0.01 (down from $0.08); revenue +11.5% but profit and margins fall on medical normalization","bullets":["Net income $1.1M vs $9.6M YoY; diluted EPS $0.01 vs $0.08.","Revenue $175.4M, +11.5% YoY on census growth to ~7,050 (+6%).","Center-level Contribution Margin $41.4M (-6.1%); margin 23.6% (down 4.4pp) on medical cost normalization and center re-openings.","Adjusted EBITDA $14.8M vs $22.6M; margin 8.4% vs 14.5%.","Company addressing audit deficiencies in Sacramento and Colorado; CEO notes COVID, labor pressures."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-22-000951","json":"https://secwatch.observer/filing/0001558370-22-000951.json","markdown":"https://secwatch.observer/filing/0001558370-22-000951.md","text":"https://secwatch.observer/filing/0001558370-22-000951.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1834376/000155837022000951/0001558370-22-000951-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1834376/000155837022000951/tmb-20220209x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T09:41:21.723152+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}